Cargando…

SAT-483 Levothyroxine Absorption Test: A Potential Therapeutic Tool for Levothyroxine Malabsorption

INTRODUCTION Persistent hypothyroidism (PH) even on high doses of levothyroxine is a common clinical problem and it is difficult to treat. Levothyroxine absorption test has been used to distinguish between pseudo-malabsorption and malabsorption as one of its causes. This test uses 1000 mcg of levoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arora, Tanureet, Chua, Lorayne Ann, Ismail-Beigi, Faramarz, Singh, Tanveer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207878/ http://dx.doi.org/10.1210/jendso/bvaa046.1162

Ejemplares similares

SAT-503 Levothyroxine Absorption Testing in Three Patients with Severe Hypothyroidism on Adequate Replacement
por: Martinez, Eduardo Andres Lopez, et al.
Publicado: (2020)

SAT-504 Delayed Hypersensitivity to Levothyroxine, and Oral Desensitization
por: Sandooja, Rashi, et al.
Publicado: (2020)

SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020)

OR19-3 Utility of the Levothyroxine Absorption Test: The Mayo Clinic Experience
por: Gonzales, Kristen, et al.
Publicado: (2019)

PSAT364 High-Dose Levothyroxine to Exclude Malabsorption as a Cause of Refractory Hypothyroidism in Hospitalized Patients: Two Cases
por: Majumdar, Sachin, et al.
Publicado: (2022)

SAT-505 Non-Adherence to Levothyroxine Treatment, a Condition Not to Be Ignored nor Forgotten, Should Be Assessed by Thyroxine Absorption Test
por: Effraimidis, Grigorios, et al.
Publicado: (2020)

SAT-425 Characteristics of Hypothyroid Patients Achieving Long Term Euthyroidism on Levothyroxine Treatment
por: Tandeter, Howard, et al.
Publicado: (2020)

SAT-608 Severe Exogenous Hyperthyroidism Secondary to Intentional Overdose of Levothyroxine in a Patient with Bipolar Disorder
por: Thapa, Sudan, et al.
Publicado: (2019)

SAT475 Levothyroxine and Liothyronine Treated Myxedema Coma with Irreversible Cardiopulmonary Failure: A Rare Phenomenon
por: Menon, Trisha, et al.
Publicado: (2023)

Levothyroxine Therapy in Gastric Malabsorptive Disorders
por: Virili, Camilla, et al.
Publicado: (2021)

SAT-443 Impact of Fasting on Plasma Thyrotropin in Hypothyroid Patients Taking Levothyroxine During Ramadan (IFT-R Study)
por: El-Kaissi, Samer, et al.
Publicado: (2020)

Development of Intranasal Levothyroxine Powder Delivery for Hypothyroidism
por: Imran, Syed Ali, et al.
Publicado: (2021)

SUN-592 Goiters and Levothyroxine Do Not Always Mix
por: Steven, Scott, et al.
Publicado: (2019)

ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)

SAT-509 Sudden Onset of Malabsorption
por: Mroueh, Gabriela, et al.
Publicado: (2020)

SAT-LB85 Use of Weekly Levothyroxine Regimen for Rapid Normalization of Thyroid Hormone Levels: A Case Report
por: Escudero, Jose Renato Martinez, et al.
Publicado: (2020)

Severe Rhabdomyolysis and Acute Renal Failure Due to Noncompliance to Levothyroxine Therapy
por: Raj, Rishi, et al.
Publicado: (2021)

A Tale of Two Therapies- A Comparison of Armour Thyroid and Levothyroxine
por: Shah, Meghna, et al.
Publicado: (2021)

ODP490 Levothyroxine Dosing Based on BMI and Different Causes of Hypothyroidism
por: Darquea, Andres, et al.
Publicado: (2022)

SAT483 Role of Cholestyramine in Refractory Amiodarone-induced Thyrotoxicosis
por: Zhao, Huaying, et al.
Publicado: (2023)

LBODP105 A Case of Significantly Increased Levothyroxine Requirement With Rifampin Therapy
por: Naher, Kamrun, et al.
Publicado: (2022)

No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects
por: Huang, Funan, et al.
Publicado: (2017)

Stopping Levothyroxine Therapy in Subclinical Hypothyroidism, Perhaps We Could Start a Trend
por: Albashaireh, Arwa, et al.
Publicado: (2021)

Myxedema Secondary to Levothyroxine Malabsorption in Newly Diagnosed Celiac Disease
por: Wiggins, Brandon, et al.
Publicado: (2022)

Levothyroxine malabsorption or pseudomalabsorption? A question in the management of refractory hypothyroidism
por: Santos Monteiro, Sílvia, et al.
Publicado: (2022)

A Rare Case of a Toxic Thyroid Nodule Found in a Hypothyroid Patient on Levothyroxine Therapy
por: Purewal, Tiffany, et al.
Publicado: (2021)

RF23 | PSAT259 Comparable Bioavailability of a Novel Levothyroxine Solution when Administered with Coffee
por: Washington, Kris, et al.
Publicado: (2022)

Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption
por: Groener, Jan B., et al.
Publicado: (2013)

Levothyroxine Tablet Malabsorption Associated with Gastroparesis Corrected with Gelatin Capsule Formulation
por: Reardon, David P., et al.
Publicado: (2016)

RF23 | PSAT365 An Open-Label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
por: Sachmechi, Issac, et al.
Publicado: (2022)

ODP476 Does Levothyroxine Intake at Breakfast Matter for Patients With Hypothyroidism? A Meta- Analysis of Randomized Control Trials
por: Cheng, Ce, et al.
Publicado: (2022)

Tea consumption affects the absorption of levothyroxine
por: Lai, Ying-Wen, et al.
Publicado: (2022)

MON-623 Higher FT4 Results in Levothyroxine-Treated Patients with Normal TSH Compared to Patients without Thyroid Disease
por: Galior, Kornelia, et al.
Publicado: (2019)

Physiologic Effects of Levothyroxine and Liothyronine in the in Older Individuals With Persistent Subclinical Hypothyroidism: A Randomized, Double-Blind, Cross-Over Study
por: Meizlik, Paige, et al.
Publicado: (2021)

ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

Adequate timing and constant supervision are the keys for successful implementation of levothyroxine or levothyroxine/paracetamol absorption test
por: Lewandowski, Krzysztof C., et al.
Publicado: (2020)

A Rare Case of Massive Pericardial Effusion as the First Presentation of Hashimoto’s Hypothyroidism With Complete Resolution With Levothyroxine Treatment - A Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2021)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

THU664 Discontinuation Of Low-dose Levothyroxine Therapy For Patients With Subclinical Hypothyroidism Is Feasible: A Pilot, Randomized, Double-blind, Placebo-controlled Trial
por: Maraka, Spyridoula, et al.
Publicado: (2023)

LBSAT247 Factors Guiding Successful Treatment Discontinuation In Levothyroxine Replacement Therapy Overuse: Short And Long-term Observation Data Of 802 Subjects.
por: Livadas, Sarantis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2s1c92piqqtnls2vfckhmtdgds